Optiscan Imaging Ltd
  • Home
  • Company
    • About Us
    • People
    • Network
    • Careers
    • Sustainability
    • Compliance
  • Portfolio
    • Portfolio
    • Technology
    • Products
      • InVue
      • InForm
      • InVivage
      • ViewnVivo
    • Pipeline
    • Publications
    • Image Gallery
    • Webinars
    • FAQ
  • Investor
    • Investor Overview
    • ASX Announcements
    • Financial Reports
    • Share Price Information
    • Investor Relations
    • Investor Alerts
  • News
    • News
    • Blog
    • Events
  • Contact
    • Contact

Select Category

  • Clinical Research
    • Oral cancer diagnosis and surgical margin
    • Brain cancer
    • General surgery
    • Cervical assessment
    • Gastrointestinal assessment
  • Life Sciences Research
    • Cell viability
    • Live antibody labelling
    • Intraoperative surgery and tumour margin delineation
    • Blood vessel, perfusion, and barrier function
    • Live microflora imaging
    • Nano particle and drug delivery
    • Proof of concept in live models

Recent Posts

  • Revolutionizing Preclinical Research: ViewnVivo® Ushers in an Era of Efficiency
  • Optiscan in the news - ASX Health Quarterly Wrap
  • Optiscan in the news: Digital Pathology Revolutionized - ASX Briefs Podcast
  • Optiscan in the news - Made in Australia: ASX firms boosting local health and medical manufacturing
  • Optiscan in the news - WTF with Optiscan: taking pathology to the digital eraWTF?!

Archives

  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • November 2022
  • September 2022
  • February 2022
  • May 2021
  • March 2021
  • January 2021
  • December 2020

Categories

  • Announcements
  • Blogs
  • Blood vessel, perfusion, and barrier function
  • Brain cancer
  • Broker Research
  • Cell viability
  • Cervical assessment
  • Gastrointestinal assessment
  • General surgery
  • Intraoperative surgery and tumour margin delineation
  • Live antibody labelling
  • Live microflora imaging
  • Nano particle and drug delivery
  • Optiscan news
  • Oral cancer diagnosis and surgical margin
  • Proof of concept in live models
  • Uncategorized
  • Veterinary

Cell viability 

Posted on 07-Nov-2022. by Optiscan

Fluorescence-Based Tracing of Transplanted Intestinal Epithelial Cells Using Confocal Laser Endomicroscopy." journal article, Stem Cell Research & Therapy 10, no. 1 (May 27 2019): 148
Jensen, Jeffrey M. Karp, and Ole Haagen Nielsen. 
In Vivo Real-Time Imaging of the Liver with Confocal Endomicroscopy Permits Visualization of the Temporospatial Patterns of Hepatocyte Apoptosis." American Journal of Physiology - Gastrointestinal and Liver Physiology 301, no. 5 (2011): G764-G72
Goetz, Martin, Jacqueline V. Ansems, Peter R. Galle, Marcus Schuchmann, and Ralf Kiesslich. 
Protein Kinase C Delta Null Mice Exhibit Structural Alterations in Articular Surface, Intra-Articular and Subchondral Compartments." journal article, Arthritis Research and Therapy 17, no. 1 (August 17 2015): 210
Yang, Xiaohong, Dian Teguh, Jian-Ping Wu, Bo He, Thomas Brett Kirk, Shengnan Qin, Siming Li, Honghui Chen, Wei Xue, Benjamin Ng, Shek Man Chim, Jennifer Tickner, Jiake %J Arthritis Research Xu, and Therapy. 

Posted in Cell viability
Optiscan Logo

Acknowledgement of Country
Optiscan Imaging acknowledges Aboriginal and Torres Strait Islander people as the Traditional Custodians of the land on which we work and live. We offer respects to Elders past, present and emerging.

Quick Links

Follow Us

Contact Us

Stay Connected

Register Your Interest

Subscribe to Investor Alerts

Follow Us

Copyright © Optiscan Imaging Ltd
Site Map Search Terms of Use Privacy Policy Cookies Policy
Site by